7,000 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
December 2021
Primary Product
ECM
Secondary Product
IPO
Date
March 2021
Primary Product
ECM
Secondary Product
IPO
Date
March 2021
Laxmi Organic Industries, is a leading manufacturer of acetyl & specialty intermediates with over three decades of experience. With leadership in ETAC & Diketene Derivatives in India, its recent foray into Fluorospecialty is backed by its experience in complex chemistries and dedicated R&D, providing a long runway for growth.
The IPO received phenomenal response from investors despite being launched in a volatile equity capital market environment in the cusp of rising bond yields and multiple equity offerings tapping the markets.
Axis Capital helped successfully close a Pre IPO of INR 200 Cr with marquee investors. As a left lead banker, Axis Capital was instrumental in handholding the company through the entire IPO process to ensure a smooth and successful closure of the transaction.
This was the 6th ECM offering in the specialty chemicals space in FY21, showcasing core domain expertise and distribution strength by procuring ~62% of the Anchor book in a 2 banker syndicate.
Transactions
13,980 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
December 2021
5,700 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
September 2021
38,500 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
August 2021
15,470 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
July 2021
8,000 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
June 2021
21,440 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
June 2021
3,000 million
Primary Product:
PE
Secondary Product:
Preference Shares
Date:
April 2021
6,000 million
Primary Product:
ECM
Secondary Product:
IPO
Date:
March 2021